img

Global Live Attenuated Vaccines for Poultry Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Live Attenuated Vaccines for Poultry Market Insights, Forecast to 2034

The global Live Attenuated Vaccines for Poultry market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Live Attenuated Vaccines for Poultry is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Live Attenuated Vaccines for Poultry is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Live Attenuated Vaccines for Poultry is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Live Attenuated Vaccines for Poultry include MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, HIPRA, Kemin Biologics, ZOETIS and Vaxxinova, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Live Attenuated Vaccines for Poultry, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Live Attenuated Vaccines for Poultry, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Live Attenuated Vaccines for Poultry, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Live Attenuated Vaccines for Poultry sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Live Attenuated Vaccines for Poultry market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Live Attenuated Vaccines for Poultry sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, HIPRA, Kemin Biologics, ZOETIS and Vaxxinova, etc.



By Company


MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
HIPRA
Kemin Biologics
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Segment by Type
Spray
Eye Drop
Oral
Others

Segment by Application


Chicken
Cattle
Horse
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Live Attenuated Vaccines for Poultry in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Live Attenuated Vaccines for Poultry manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live Attenuated Vaccines for Poultry sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Live Attenuated Vaccines for Poultry Product Introduction
1.2 Market by Type
1.2.1 Global Live Attenuated Vaccines for Poultry Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Spray
1.2.3 Eye Drop
1.2.4 Oral
1.2.5 Others
1.3 Market by Application
1.3.1 Global Live Attenuated Vaccines for Poultry Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Chicken
1.3.3 Cattle
1.3.4 Horse
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Live Attenuated Vaccines for Poultry Sales Estimates and Forecasts 2018-2034
2.2 Global Live Attenuated Vaccines for Poultry Revenue by Region
2.2.1 Global Live Attenuated Vaccines for Poultry Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Live Attenuated Vaccines for Poultry Revenue by Region (2018-2024)
2.2.3 Global Live Attenuated Vaccines for Poultry Revenue by Region (2024-2034)
2.2.4 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2018-2034)
2.3 Global Live Attenuated Vaccines for Poultry Sales Estimates and Forecasts 2018-2034
2.4 Global Live Attenuated Vaccines for Poultry Sales by Region
2.4.1 Global Live Attenuated Vaccines for Poultry Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Live Attenuated Vaccines for Poultry Sales by Region (2018-2024)
2.4.3 Global Live Attenuated Vaccines for Poultry Sales by Region (2024-2034)
2.4.4 Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Live Attenuated Vaccines for Poultry Sales by Manufacturers
3.1.1 Global Live Attenuated Vaccines for Poultry Sales by Manufacturers (2018-2024)
3.1.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Live Attenuated Vaccines for Poultry in 2022
3.2 Global Live Attenuated Vaccines for Poultry Revenue by Manufacturers
3.2.1 Global Live Attenuated Vaccines for Poultry Revenue by Manufacturers (2018-2024)
3.2.2 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Live Attenuated Vaccines for Poultry Revenue in 2022
3.3 Global Key Players of Live Attenuated Vaccines for Poultry, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Live Attenuated Vaccines for Poultry Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Product Offered and Application
3.8 Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Live Attenuated Vaccines for Poultry Sales by Type
4.1.1 Global Live Attenuated Vaccines for Poultry Historical Sales by Type (2018-2024)
4.1.2 Global Live Attenuated Vaccines for Poultry Forecasted Sales by Type (2024-2034)
4.1.3 Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
4.2 Global Live Attenuated Vaccines for Poultry Revenue by Type
4.2.1 Global Live Attenuated Vaccines for Poultry Historical Revenue by Type (2018-2024)
4.2.2 Global Live Attenuated Vaccines for Poultry Forecasted Revenue by Type (2024-2034)
4.2.3 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
4.3 Global Live Attenuated Vaccines for Poultry Price by Type
4.3.1 Global Live Attenuated Vaccines for Poultry Price by Type (2018-2024)
4.3.2 Global Live Attenuated Vaccines for Poultry Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Live Attenuated Vaccines for Poultry Sales by Application
5.1.1 Global Live Attenuated Vaccines for Poultry Historical Sales by Application (2018-2024)
5.1.2 Global Live Attenuated Vaccines for Poultry Forecasted Sales by Application (2024-2034)
5.1.3 Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
5.2 Global Live Attenuated Vaccines for Poultry Revenue by Application
5.2.1 Global Live Attenuated Vaccines for Poultry Historical Revenue by Application (2018-2024)
5.2.2 Global Live Attenuated Vaccines for Poultry Forecasted Revenue by Application (2024-2034)
5.2.3 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
5.3 Global Live Attenuated Vaccines for Poultry Price by Application
5.3.1 Global Live Attenuated Vaccines for Poultry Price by Application (2018-2024)
5.3.2 Global Live Attenuated Vaccines for Poultry Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Live Attenuated Vaccines for Poultry Market Size by Type
6.1.1 US & Canada Live Attenuated Vaccines for Poultry Sales by Type (2018-2034)
6.1.2 US & Canada Live Attenuated Vaccines for Poultry Revenue by Type (2018-2034)
6.2 US & Canada Live Attenuated Vaccines for Poultry Market Size by Application
6.2.1 US & Canada Live Attenuated Vaccines for Poultry Sales by Application (2018-2034)
6.2.2 US & Canada Live Attenuated Vaccines for Poultry Revenue by Application (2018-2034)
6.3 US & Canada Live Attenuated Vaccines for Poultry Market Size by Country
6.3.1 US & Canada Live Attenuated Vaccines for Poultry Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Live Attenuated Vaccines for Poultry Sales by Country (2018-2034)
6.3.3 US & Canada Live Attenuated Vaccines for Poultry Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Live Attenuated Vaccines for Poultry Market Size by Type
7.1.1 Europe Live Attenuated Vaccines for Poultry Sales by Type (2018-2034)
7.1.2 Europe Live Attenuated Vaccines for Poultry Revenue by Type (2018-2034)
7.2 Europe Live Attenuated Vaccines for Poultry Market Size by Application
7.2.1 Europe Live Attenuated Vaccines for Poultry Sales by Application (2018-2034)
7.2.2 Europe Live Attenuated Vaccines for Poultry Revenue by Application (2018-2034)
7.3 Europe Live Attenuated Vaccines for Poultry Market Size by Country
7.3.1 Europe Live Attenuated Vaccines for Poultry Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Live Attenuated Vaccines for Poultry Sales by Country (2018-2034)
7.3.3 Europe Live Attenuated Vaccines for Poultry Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Live Attenuated Vaccines for Poultry Market Size
8.1.1 China Live Attenuated Vaccines for Poultry Sales (2018-2034)
8.1.2 China Live Attenuated Vaccines for Poultry Revenue (2018-2034)
8.2 China Live Attenuated Vaccines for Poultry Market Size by Application
8.2.1 China Live Attenuated Vaccines for Poultry Sales by Application (2018-2034)
8.2.2 China Live Attenuated Vaccines for Poultry Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Live Attenuated Vaccines for Poultry Market Size by Type
9.1.1 Asia Live Attenuated Vaccines for Poultry Sales by Type (2018-2034)
9.1.2 Asia Live Attenuated Vaccines for Poultry Revenue by Type (2018-2034)
9.2 Asia Live Attenuated Vaccines for Poultry Market Size by Application
9.2.1 Asia Live Attenuated Vaccines for Poultry Sales by Application (2018-2034)
9.2.2 Asia Live Attenuated Vaccines for Poultry Revenue by Application (2018-2034)
9.3 Asia Live Attenuated Vaccines for Poultry Sales by Region
9.3.1 Asia Live Attenuated Vaccines for Poultry Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Live Attenuated Vaccines for Poultry Revenue by Region (2018-2034)
9.3.3 Asia Live Attenuated Vaccines for Poultry Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Market Size by Type
10.1.1 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Market Size by Application
10.2.1 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Country
10.3.1 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 MERCK
11.1.1 MERCK Company Information
11.1.2 MERCK Overview
11.1.3 MERCK Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 MERCK Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MERCK Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 ELANCO
11.3.1 ELANCO Company Information
11.3.2 ELANCO Overview
11.3.3 ELANCO Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 ELANCO Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ELANCO Recent Developments
11.4 QYH BIOTECH
11.4.1 QYH BIOTECH Company Information
11.4.2 QYH BIOTECH Overview
11.4.3 QYH BIOTECH Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 QYH BIOTECH Recent Developments
11.5 CEVA
11.5.1 CEVA Company Information
11.5.2 CEVA Overview
11.5.3 CEVA Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 CEVA Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CEVA Recent Developments
11.6 HIPRA
11.6.1 HIPRA Company Information
11.6.2 HIPRA Overview
11.6.3 HIPRA Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 HIPRA Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HIPRA Recent Developments
11.7 Kemin Biologics
11.7.1 Kemin Biologics Company Information
11.7.2 Kemin Biologics Overview
11.7.3 Kemin Biologics Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Kemin Biologics Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kemin Biologics Recent Developments
11.8 ZOETIS
11.8.1 ZOETIS Company Information
11.8.2 ZOETIS Overview
11.8.3 ZOETIS Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 ZOETIS Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ZOETIS Recent Developments
11.9 Vaxxinova
11.9.1 Vaxxinova Company Information
11.9.2 Vaxxinova Overview
11.9.3 Vaxxinova Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Vaxxinova Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vaxxinova Recent Developments
11.10 PULIKE
11.10.1 PULIKE Company Information
11.10.2 PULIKE Overview
11.10.3 PULIKE Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 PULIKE Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PULIKE Recent Developments
11.11 PHIBRO ANIMAL HEALTH CORPORATION
11.11.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
11.11.2 PHIBRO ANIMAL HEALTH CORPORATION Overview
11.11.3 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
11.12 JINYU BIOTECHNOLOGY
11.12.1 JINYU BIOTECHNOLOGY Company Information
11.12.2 JINYU BIOTECHNOLOGY Overview
11.12.3 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 JINYU BIOTECHNOLOGY Recent Developments
11.13 HARBIN PHARMACEUTICAL GROUP
11.13.1 HARBIN PHARMACEUTICAL GROUP Company Information
11.13.2 HARBIN PHARMACEUTICAL GROUP Overview
11.13.3 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 HARBIN PHARMACEUTICAL GROUP Recent Developments
11.14 MEVAC
11.14.1 MEVAC Company Information
11.14.2 MEVAC Overview
11.14.3 MEVAC Live Attenuated Vaccines for Poultry Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 MEVAC Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 MEVAC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Live Attenuated Vaccines for Poultry Industry Chain Analysis
12.2 Live Attenuated Vaccines for Poultry Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Live Attenuated Vaccines for Poultry Production Mode & Process
12.4 Live Attenuated Vaccines for Poultry Sales and Marketing
12.4.1 Live Attenuated Vaccines for Poultry Sales Channels
12.4.2 Live Attenuated Vaccines for Poultry Distributors
12.5 Live Attenuated Vaccines for Poultry Customers
13 Market Dynamics
13.1 Live Attenuated Vaccines for Poultry Industry Trends
13.2 Live Attenuated Vaccines for Poultry Market Drivers
13.3 Live Attenuated Vaccines for Poultry Market Challenges
13.4 Live Attenuated Vaccines for Poultry Market Restraints
14 Key Findings in The Global Live Attenuated Vaccines for Poultry Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Live Attenuated Vaccines for Poultry Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Spray
Table 3. Major Manufacturers of Eye Drop
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Others
Table 6. Global Live Attenuated Vaccines for Poultry Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Live Attenuated Vaccines for Poultry Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Live Attenuated Vaccines for Poultry Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Live Attenuated Vaccines for Poultry Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2018-2024)
Table 11. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2024-2034)
Table 12. Global Live Attenuated Vaccines for Poultry Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 13. Global Live Attenuated Vaccines for Poultry Sales by Region (2018-2024) & (K Units)
Table 14. Global Live Attenuated Vaccines for Poultry Sales by Region (2024-2034) & (K Units)
Table 15. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2018-2024)
Table 16. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2024-2034)
Table 17. Global Live Attenuated Vaccines for Poultry Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Live Attenuated Vaccines for Poultry Sales Share by Manufacturers (2018-2024)
Table 19. Global Live Attenuated Vaccines for Poultry Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Live Attenuated Vaccines for Poultry, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Live Attenuated Vaccines for Poultry Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Live Attenuated Vaccines for Poultry Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Live Attenuated Vaccines for Poultry by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines for Poultry as of 2022)
Table 25. Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Product Offered and Application
Table 27. Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Live Attenuated Vaccines for Poultry Sales by Type (2018-2024) & (K Units)
Table 30. Global Live Attenuated Vaccines for Poultry Sales by Type (2024-2034) & (K Units)
Table 31. Global Live Attenuated Vaccines for Poultry Sales Share by Type (2018-2024)
Table 32. Global Live Attenuated Vaccines for Poultry Sales Share by Type (2024-2034)
Table 33. Global Live Attenuated Vaccines for Poultry Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Live Attenuated Vaccines for Poultry Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Live Attenuated Vaccines for Poultry Revenue Share by Type (2018-2024)
Table 36. Global Live Attenuated Vaccines for Poultry Revenue Share by Type (2024-2034)
Table 37. Live Attenuated Vaccines for Poultry Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Live Attenuated Vaccines for Poultry Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global Live Attenuated Vaccines for Poultry Sales by Application (2018-2024) & (K Units)
Table 40. Global Live Attenuated Vaccines for Poultry Sales by Application (2024-2034) & (K Units)
Table 41. Global Live Attenuated Vaccines for Poultry Sales Share by Application (2018-2024)
Table 42. Global Live Attenuated Vaccines for Poultry Sales Share by Application (2024-2034)
Table 43. Global Live Attenuated Vaccines for Poultry Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Live Attenuated Vaccines for Poultry Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Live Attenuated Vaccines for Poultry Revenue Share by Application (2018-2024)
Table 46. Global Live Attenuated Vaccines for Poultry Revenue Share by Application (2024-2034)
Table 47. Live Attenuated Vaccines for Poultry Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Live Attenuated Vaccines for Poultry Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. US & Canada Live Attenuated Vaccines for Poultry Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Live Attenuated Vaccines for Poultry Sales by Type (2024-2034) & (K Units)
Table 51. US & Canada Live Attenuated Vaccines for Poultry Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Live Attenuated Vaccines for Poultry Revenue by Type (2024-2034) & (US$ Million)
Table 53. US & Canada Live Attenuated Vaccines for Poultry Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Live Attenuated Vaccines for Poultry Sales by Application (2024-2034) & (K Units)
Table 55. US & Canada Live Attenuated Vaccines for Poultry Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Live Attenuated Vaccines for Poultry Revenue by Application (2024-2034) & (US$ Million)
Table 57. US & Canada Live Attenuated Vaccines for Poultry Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. US & Canada Live Attenuated Vaccines for Poultry Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Live Attenuated Vaccines for Poultry Revenue by Country (2024-2034) & (US$ Million)
Table 60. US & Canada Live Attenuated Vaccines for Poultry Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Live Attenuated Vaccines for Poultry Sales by Country (2024-2034) & (K Units)
Table 62. Europe Live Attenuated Vaccines for Poultry Sales by Type (2018-2024) & (K Units)
Table 63. Europe Live Attenuated Vaccines for Poultry Sales by Type (2024-2034) & (K Units)
Table 64. Europe Live Attenuated Vaccines for Poultry Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Live Attenuated Vaccines for Poultry Revenue by Type (2024-2034) & (US$ Million)
Table 66. Europe Live Attenuated Vaccines for Poultry Sales by Application (2018-2024) & (K Units)
Table 67. Europe Live Attenuated Vaccines for Poultry Sales by Application (2024-2034) & (K Units)
Table 68. Europe Live Attenuated Vaccines for Poultry Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Live Attenuated Vaccines for Poultry Revenue by Application (2024-2034) & (US$ Million)
Table 70. Europe Live Attenuated Vaccines for Poultry Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 71. Europe Live Attenuated Vaccines for Poultry Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Live Attenuated Vaccines for Poultry Revenue by Country (2024-2034) & (US$ Million)
Table 73. Europe Live Attenuated Vaccines for Poultry Sales by Country (2018-2024) & (K Units)
Table 74. Europe Live Attenuated Vaccines for Poultry Sales by Country (2024-2034) & (K Units)
Table 75. China Live Attenuated Vaccines for Poultry Sales by Type (2018-2024) & (K Units)
Table 76. China Live Attenuated Vaccines for Poultry Sales by Type (2024-2034) & (K Units)
Table 77. China Live Attenuated Vaccines for Poultry Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Live Attenuated Vaccines for Poultry Revenue by Type (2024-2034) & (US$ Million)
Table 79. China Live Attenuated Vaccines for Poultry Sales by Application (2018-2024) & (K Units)
Table 80. China Live Attenuated Vaccines for Poultry Sales by Application (2024-2034) & (K Units)
Table 81. China Live Attenuated Vaccines for Poultry Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Live Attenuated Vaccines for Poultry Revenue by Application (2024-2034) & (US$ Million)
Table 83. Asia Live Attenuated Vaccines for Poultry Sales by Type (2018-2024) & (K Units)
Table 84. Asia Live Attenuated Vaccines for Poultry Sales by Type (2024-2034) & (K Units)
Table 85. Asia Live Attenuated Vaccines for Poultry Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Live Attenuated Vaccines for Poultry Revenue by Type (2024-2034) & (US$ Million)
Table 87. Asia Live Attenuated Vaccines for Poultry Sales by Application (2018-2024) & (K Units)
Table 88. Asia Live Attenuated Vaccines for Poultry Sales by Application (2024-2034) & (K Units)
Table 89. Asia Live Attenuated Vaccines for Poultry Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Live Attenuated Vaccines for Poultry Revenue by Application (2024-2034) & (US$ Million)
Table 91. Asia Live Attenuated Vaccines for Poultry Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 92. Asia Live Attenuated Vaccines for Poultry Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Live Attenuated Vaccines for Poultry Revenue by Region (2024-2034) & (US$ Million)
Table 94. Asia Live Attenuated Vaccines for Poultry Sales by Region (2018-2024) & (K Units)
Table 95. Asia Live Attenuated Vaccines for Poultry Sales by Region (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Type (2024-2034) & (K Units)
Table 98. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Type (2024-2034) & (US$ Million)
Table 100. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Application (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Application (2024-2034) & (US$ Million)
Table 104. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 105. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue by Country (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales by Country (2024-2034) & (K Units)
Table 109. MERCK Company Information
Table 110. MERCK Description and Major Businesses
Table 111. MERCK Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. MERCK Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. MERCK Recent Developments
Table 114. Boehringer Ingelheim Company Information
Table 115. Boehringer Ingelheim Description and Major Businesses
Table 116. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Boehringer Ingelheim Recent Developments
Table 119. ELANCO Company Information
Table 120. ELANCO Description and Major Businesses
Table 121. ELANCO Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. ELANCO Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. ELANCO Recent Developments
Table 124. QYH BIOTECH Company Information
Table 125. QYH BIOTECH Description and Major Businesses
Table 126. QYH BIOTECH Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. QYH BIOTECH Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. QYH BIOTECH Recent Developments
Table 129. CEVA Company Information
Table 130. CEVA Description and Major Businesses
Table 131. CEVA Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. CEVA Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. CEVA Recent Developments
Table 134. HIPRA Company Information
Table 135. HIPRA Description and Major Businesses
Table 136. HIPRA Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. HIPRA Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. HIPRA Recent Developments
Table 139. Kemin Biologics Company Information
Table 140. Kemin Biologics Description and Major Businesses
Table 141. Kemin Biologics Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Kemin Biologics Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Kemin Biologics Recent Developments
Table 144. ZOETIS Company Information
Table 145. ZOETIS Description and Major Businesses
Table 146. ZOETIS Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. ZOETIS Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. ZOETIS Recent Developments
Table 149. Vaxxinova Company Information
Table 150. Vaxxinova Description and Major Businesses
Table 151. Vaxxinova Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Vaxxinova Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Vaxxinova Recent Developments
Table 154. PULIKE Company Information
Table 155. PULIKE Description and Major Businesses
Table 156. PULIKE Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. PULIKE Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. PULIKE Recent Developments
Table 159. PHIBRO ANIMAL HEALTH CORPORATION Company Information
Table 160. PHIBRO ANIMAL HEALTH CORPORATION Description and Major Businesses
Table 161. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
Table 164. JINYU BIOTECHNOLOGY Company Information
Table 165. JINYU BIOTECHNOLOGY Description and Major Businesses
Table 166. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. JINYU BIOTECHNOLOGY Recent Developments
Table 169. HARBIN PHARMACEUTICAL GROUP Company Information
Table 170. HARBIN PHARMACEUTICAL GROUP Description and Major Businesses
Table 171. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. HARBIN PHARMACEUTICAL GROUP Recent Developments
Table 174. MEVAC Company Information
Table 175. MEVAC Description and Major Businesses
Table 176. MEVAC Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. MEVAC Live Attenuated Vaccines for Poultry Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. MEVAC Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Live Attenuated Vaccines for Poultry Distributors List
Table 182. Live Attenuated Vaccines for Poultry Customers List
Table 183. Live Attenuated Vaccines for Poultry Market Trends
Table 184. Live Attenuated Vaccines for Poultry Market Drivers
Table 185. Live Attenuated Vaccines for Poultry Market Challenges
Table 186. Live Attenuated Vaccines for Poultry Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Live Attenuated Vaccines for Poultry Product Picture
Figure 2. Global Live Attenuated Vaccines for Poultry Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Live Attenuated Vaccines for Poultry Market Share by Type in 2022 & 2034
Figure 4. Spray Product Picture
Figure 5. Eye Drop Product Picture
Figure 6. Oral Product Picture
Figure 7. Others Product Picture
Figure 8. Global Live Attenuated Vaccines for Poultry Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Live Attenuated Vaccines for Poultry Market Share by Application in 2022 & 2034
Figure 10. Chicken
Figure 11. Cattle
Figure 12. Horse
Figure 13. Others
Figure 14. Live Attenuated Vaccines for Poultry Report Years Considered
Figure 15. Global Live Attenuated Vaccines for Poultry Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Live Attenuated Vaccines for Poultry Revenue 2018-2034 (US$ Million)
Figure 17. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2018-2034)
Figure 19. Global Live Attenuated Vaccines for Poultry Sales 2018-2034 ((K Units)
Figure 20. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2018-2034)
Figure 21. US & Canada Live Attenuated Vaccines for Poultry Sales YoY (2018-2034) & (K Units)
Figure 22. US & Canada Live Attenuated Vaccines for Poultry Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Live Attenuated Vaccines for Poultry Sales YoY (2018-2034) & (K Units)
Figure 24. Europe Live Attenuated Vaccines for Poultry Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Live Attenuated Vaccines for Poultry Sales YoY (2018-2034) & (K Units)
Figure 26. China Live Attenuated Vaccines for Poultry Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Asia (excluding China) Live Attenuated Vaccines for Poultry Sales YoY (2018-2034) & (K Units)
Figure 28. Asia (excluding China) Live Attenuated Vaccines for Poultry Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Live Attenuated Vaccines for Poultry Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Live Attenuated Vaccines for Poultry in the World: Market Share by Live Attenuated Vaccines for Poultry Revenue in 2022
Figure 33. Global Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
Figure 35. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
Figure 36. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
Figure 37. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
Figure 39. US & Canada Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
Figure 40. US & Canada Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
Figure 41. US & Canada Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
Figure 42. US & Canada Live Attenuated Vaccines for Poultry Revenue Share by Country (2018-2034)
Figure 43. US & Canada Live Attenuated Vaccines for Poultry Sales Share by Country (2018-2034)
Figure 44. U.S. Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
Figure 47. Europe Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
Figure 48. Europe Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
Figure 49. Europe Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
Figure 50. Europe Live Attenuated Vaccines for Poultry Revenue Share by Country (2018-2034)
Figure 51. Europe Live Attenuated Vaccines for Poultry Sales Share by Country (2018-2034)
Figure 52. Germany Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 53. France Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 57. China Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
Figure 58. China Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
Figure 59. China Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
Figure 60. China Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
Figure 61. Asia Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
Figure 62. Asia Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
Figure 63. Asia Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
Figure 64. Asia Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
Figure 65. Asia Live Attenuated Vaccines for Poultry Revenue Share by Region (2018-2034)
Figure 66. Asia Live Attenuated Vaccines for Poultry Sales Share by Region (2018-2034)
Figure 67. Japan Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 68. South Korea Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 69. China Taiwan Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 70. Southeast Asia Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 71. India Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2018-2034)
Figure 74. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2018-2034)
Figure 76. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Revenue Share by Country (2018-2034)
Figure 77. Middle East, Africa and Latin America Live Attenuated Vaccines for Poultry Sales Share by Country (2018-2034)
Figure 78. Brazil Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 79. Mexico Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 80. Turkey Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 81. Israel Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 82. GCC Countries Live Attenuated Vaccines for Poultry Revenue (2018-2034) & (US$ Million)
Figure 83. Live Attenuated Vaccines for Poultry Value Chain
Figure 84. Live Attenuated Vaccines for Poultry Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed